Por favor, use este identificador para citar o enlazar este ítem:
https://hdl.handle.net/11000/30948
Registro completo de metadatos
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Cano, Antonio | - |
dc.contributor.author | Silvan, José Manuel | - |
dc.contributor.author | Estévez, Antonio | - |
dc.contributor.author | Baró, Francesc | - |
dc.contributor.author | Villero, José | - |
dc.contributor.author | Quereda Seguí, Francisco José | - |
dc.contributor.author | Ferrer, Javier | - |
dc.contributor.author | Mendoza, Nicolás | - |
dc.contributor.author | Sánchez Borrego, Rafael | - |
dc.contributor.other | Departamentos de la UMH::Salud Pública, Historia de la Ciencia y Ginecología | es_ES |
dc.date.accessioned | 2024-02-02T09:09:24Z | - |
dc.date.available | 2024-02-02T09:09:24Z | - |
dc.date.created | 2014-09 | - |
dc.identifier.citation | Maturitas Supports open access Volume 79, Issue 1, September 2014, Pages 117-121 | es_ES |
dc.identifier.issn | 0378-5122 | - |
dc.identifier.issn | 1873-4111 | - |
dc.identifier.uri | https://hdl.handle.net/11000/30948 | - |
dc.description.abstract | Denosumab is a new drug developed for the treatment of osteoporosis. Moreover, increasing evidences link denosumab with benefits in cancer, an area of interest for those in charge of the postmenopausal health. Denosumab has shown efficacy in the control of bone loss associated with hypogonadic states created by chemotherapy in breast and other cancers. Moreover, some studies reveal efficacy in reducing the progression of metastases. A panel of experts from the Spanish Menopause Society has met to develop usage recommendations based on the best available evidence. | es_ES |
dc.format | application/pdf | es_ES |
dc.format.extent | 5 | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Elsevier [Commercial Publisher] | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Denosumab | es_ES |
dc.subject | Postmenopausal osteoporosis | es_ES |
dc.subject | Breast cancer | es_ES |
dc.title | Spanish Menopause Society position statement: Use of denosumab in postmenopausal women | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.relation.publisherversion | https://doi.org/10.1016/j.maturitas.2014.06.011 | es_ES |
![Vista previa](/jspui/retrieve/72ce4b56-b25c-421f-ae23-71b570d0c3ff/Spanish%20Menopause%20Society%20position%20statement%20Use%20of%20denosumab%20in.pdf.jpg)
Ver/Abrir:
Spanish Menopause Society position statement Use of denosumab in.pdf
560,52 kB
Adobe PDF
Compartir:
La licencia se describe como: Atribución-NonComercial-NoDerivada 4.0 Internacional.